Joo Diogo Barros Silva
Joo Diogo Barros Silva
Postdoctoral scientist, University of Birmingham
Email verificata su bham.ac.uk - Home page
Titolo
Citata da
Citata da
Anno
Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients
JD Barros-Silva, D Leitao, L Afonso, J Vieira, M Dinis-Ribeiro, M Fragoso, ...
British journal of cancer 100 (3), 487-493, 2009
2242009
FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer
P Paulo, JD Barros‐Silva, FR Ribeiro, J Ramalho‐Carvalho, C Jernimo, ...
Genes, Chromosomes and Cancer 51 (3), 240-249, 2012
832012
Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements
P Paulo, FR Ribeiro, J Santos, D Mesquita, M Almeida, JD Barros-Silva, ...
Neoplasia 14 (7), 600-IN15, 2012
822012
Cysteine-rich secretory protein-3 (CRISP3) is strongly up-regulated in prostate carcinomas with the TMPRSS2-ERG fusion gene
FR Ribeiro, P Paulo, VL Costa, JD Barros-Silva, J Ramalho-Carvalho, ...
PloS one 6 (7), e22317, 2011
542011
Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation
A Gusev, H Shi, G Kichaev, M Pomerantz, F Li, HW Long, SA Ingles, ...
Nature communications 7 (1), 1-13, 2016
432016
Novel 5′ fusion partners of ETV1 and ETV4 in prostate cancer
JD Barros-Silva, P Paulo, AC Bakken, N Cerveira, M Lvf, R Henrique, ...
Neoplasia 15 (7), 720-IN6, 2013
392013
Feasibility of differential diagnosis of kidney tumors by comparative genomic hybridization of fine needle aspiration biopsies
J Vieira, R Henrique, FR Ribeiro, JD Barros‐Silva, A Peixoto, C Santos, ...
Genes, Chromosomes and Cancer 49 (10), 935-947, 2010
392010
Altered expression of MGMT in high-grade gliomas results from the combined effect of epigenetic and genetic aberrations
J Ramalho-Carvalho, M Pires, S Lisboa, I Graa, P Rocha, ...
PLoS One 8 (3), e58206, 2013
382013
Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing’s sarcoma and prostate carcinoma
MJ Cames, P Paulo, FR Ribeiro, JD Barros-Silva, M Almeida, VL Costa, ...
PloS one 7 (11), e49819, 2012
352012
Single-cell analysis identifies LY6D as a marker linking castration-resistant prostate luminal cells to prostate progenitors and cancer
JD Barros-Silva, DE Linn, I Steiner, G Guo, A Ali, H Pakula, G Ashton, ...
Cell reports 25 (12), 3504-3518. e6, 2018
342018
Relative 8q gain predicts disease‐specific survival irrespective of the TMPRSS2‐ERG fusion status in diagnostic biopsies of prostate cancer
JD Barros‐Silva, FR Ribeiro, Rodrigues, R Cruz, AT Martins, ...
Genes, Chromosomes and Cancer 50 (8), 662-671, 2011
332011
Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution
N Cerveira, S Lisboa, C Correia, S Bizarro, J Santos, L Torres, J Vieira, ...
Molecular oncology 6 (5), 553-564, 2012
262012
Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts
D Mesquita, JD Barros-Silva, J Santos, RI Skotheim, RA Lothe, P Paulo, ...
Oncotarget 6 (7), 5217, 2015
232015
Common fusion transcripts identified in colorectal cancer cell lines by high-throughput RNA sequencing
T Nome, GOS Thomassen, J Bruun, T Ahlquist, AC Bakken, AM Hoff, ...
Translational oncology 6 (5), 546-IN5, 2013
222013
Genomic evaluation of multiparametric magnetic resonance imaging-visible and-nonvisible lesions in clinically localised prostate cancer
MA Parry, S Srivastava, A Ali, A Cannistraci, J Antonello, JD Barros-Silva, ...
European urology oncology 2 (1), 1-11, 2019
212019
Deregulation of PAX 2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis
P Patrcio, J Ramalho‐Carvalho, P Costa‐Pinheiro, M Almeida, ...
Journal of cellular and molecular medicine 17 (8), 1048-1058, 2013
202013
Prostate cancer prognosis defined by the combined analysis of 8q, PTEN and ERG
MP Silva, JD Barros-Silva, E Ersvr, W Kildal, TS Hveem, M Pradhan, ...
Translational oncology 9 (6), 575-582, 2016
162016
Uncovering potential downstream targets of oncogenic GRPR overexpression in prostate carcinomas harboring ETS rearrangements
J Santos, D Mesquita, JD Barros-Silva, C Jernimo, R Henrique, A Morais, ...
Oncoscience 2 (5), 497, 2015
122015
Radiosensitising cancer using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or mammalian target of rapamycin (mTOR) Inhibitors
K Wanigasooriya, R Tyler, JD Barros-Silva, Y Sinha, T Ismail, AD Beggs
Cancers 12 (5), 1278, 2020
102020
NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer
MP Silva, JD Barros‐Silva, J Vieira, S Lisboa, L Torres, C Correia, ...
Genes, Chromosomes and Cancer 55 (4), 365-374, 2016
92016
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20